Contemporary Nursing
Contemporary Nursing. 2024; 5: (10) ; 10.12208/j.cn.20241529 .
总浏览量: 133
保定市第一中心医院 河北保定
*通讯作者： 李雪丽,单位：保定市第一中心医院 河北保定；
乳腺癌是我国女性发病率居首位的恶性肿瘤，病死率居第四位，且均呈上升趋势。在临床上，乳腺癌患者推荐留置中心静脉导管进行化疗，它的留置时间长，可以有效避免药物外渗造成的渗透性损伤。置管后容易导致血栓形成，也就是导管相关的血栓形成。概述乳腺癌中心静脉血栓的研究现状，分别从发生率、危险因素等方面进行了总结，旨在为导管相关血栓的风险评估、诊断和防治提供借鉴。
Breast cancer is the most common malignant tumor in women in China, and the mortality rate ranks fourth, and both of them show an increasing trend. Clinically, breast cancer patients are recommended to have an indwelling central venous catheter for chemotherapy, which has a long indwelling time and can effectively avoid osmotic damage caused by drug extravasation. Catheterization can easily lead to thrombosis, also known as catheter-related thrombosis. This paper summarizes the research status of central venous thrombosis in breast cancer, and summarizes the incidence and risk factors, aiming to provide reference for the risk assessment, diagnosis and prevention of catheter-related thrombosis.
[1] 侯思浩,周毅,乳腺癌导管相关性血栓研究进展. 安徽医,2023,27(2):230-235.
[2] 王浩,侯朝铭,高静等,中国乳腺癌患者静脉血栓危险因素Meta分析.河南外科学杂志,2023,29(01):22-27.
[3] 李静,强万敏,张方圆等.构建乳腺癌患者静脉血栓栓塞症风险预测模型. 护理研究,2020,34(16):2852-2857.
[4] 李慧妍邵群张志仁导管相关性血栓研究进展.肿瘤综合治疗电子杂志,2019,5(03):8-12.
[5] KUCHER, NILS. Deep-vein thrombosis of the upper extremities[J]. N Engl J Med,2011, 364(9):861-869.
[6] DEBOURDEAU P, ESPIÉ M, CHEVRET S, et al. Incidence, risk factors, and outcomes of central venous catheter-related thromboembolism in breast cancer patients: the CAVECCAS study[J]. Cancer Med,2017,6(11):2732-2744.
[7] 石果,罗凤,张玲; 172例乳腺癌输液港静脉血栓相关因素分析.重庆医科大学学报,2016,41(05):530-532.
[8] 苏泽隆李文玲陈浩鑫等乳腺癌化疗病人PICC相关性静脉血栓危险因素分析.广东医学,2022,43(12):1569-1572.
[9] 王德光,谭春玲,王洪燕等乳腺癌深静脉静脉血栓栓塞症危险因素的Meta分析.中国现代普通外科进展,2022, 25(06):444-450.
[10] LEE AYY, LEVINE MN, BUTLER G, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer[J]. J Clin Oncol,2006,24(9): 1404-1408.
[11] Schears G J , Ferko N , Syed I ,et al. Peripherally inserted central catheters inserted with current best practices have low deep vein thrombosis and central line–associated bloodstream infection risk compared with centrally inserted central catheters: A contemporary meta-analysis:[J].The Journal of Vascular Access, 2021, 22(1):9-25.
[12] 刘利,张旭,刘晓玲癌症患者PICC导管相关性静脉血栓危险因素及风险评估研究进展.全科护理,2022, 20(30): 4222-4225.
[13] 张欣,朱玉欣,高亚伟等不同材质和结构导管对肿瘤病人PICC置管后血栓形成的影响.河北医药,2021, 43(05): 684-687+692.
[14] CHOPRA V, ANAND S, HICKNER A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis[J]. Lancet,2013,382(9889):311-325.
[15] MA L, LIU YP, WANG JX, et al. Totally implantable venous accessport systems and associated complications: a single-institution retrospective analysis of 2 996 breast cancer patients[J]. MolClin Oncol,2016,4(3):456-460.
[16] Razouki ZA, Ali NT, Nguyen VQ, Escalante CP. Risk factors associated with venous thromboembolism in breast cancer: a narrative review[J]. Support Care Cancer. 2022;30(10):8589-8597.
[17] 王德光,王洪燕,谭春玲,等.乳腺癌患者发生静脉血栓栓塞症危险因素分析[J].创伤与急危重病医学,2021,9(02): 116-119.
[18] GAO Y, LIU Y, CHEN W, et al. Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients:a double-center prospective investigation[J]. Ther Clin Risk Manag, 2015, 11:153-160.
[19] 娄幼幼,林娇,王玉玲乳腺癌化疗患者输液,并发血栓的危险因素及应对措施.医院管理论坛,2020,37(10):35-37.
[20] Previtali E, Bucciarelli P, Passamonti SM, et al.Risk factors for venous and arterial thrombosis[J]. Blood Transfus. 2011;9(2):120-138.
[21] Nolan L, Darby A, Boleti K,et al.The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer [J]. Breast. 2011;20(2):151-154.
[22] 吴坤,蔡永兰. PICC静脉血栓形成原因分析及护理[J]. 中国社区医师(医学专业),2012,14(2):353-354.